The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
AGA Clinical Practice Update: Coagulation in Cirrhosis
Abstract
DESCRIPTION This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership. The intent is to evaluate the current data on mechanism of altered coagulation in patients with cirrhosis, provide guidance on the use of currently available testing of the coagulation cascade, and help practitioners use anticoagulation and pro-coagulants appropriately in patients with cirrhosis. METHODS This review is framed around the best practice points, which were derived from the most impactful publications in the area of coagulation in cirrhosis and agreed to by all authors. BEST PRACTICE ADVICE 1: Global tests of clot formation, such as rotational thromboelastometry, thromboelastography, sonorheometry, and thrombin generation, may eventually have a role in the evaluation of clotting in patients with cirrhosis, but currently lack validated target levels. BEST PRACTICE ADVICE 2: In general, clinicians should not routinely correct thrombocytopenia and coagulopathy before low-risk therapeutic paracentesis, thoracentesis, and routine upper endoscopy for variceal ligation in patients with hepatic synthetic dysfunction-induced coagulation abnormalities. BEST PRACTICE ADVICE 3: Blood products should be used sparingly because they increase portal pressure and carry a risk of transfusion-associated circulatory overload, transfusion-related acute lung injury, infection transmission, alloimmunization, and/or transfusion reactions. BEST PRACTICE ADVICE 4: The following transfusion thresholds for management of active bleeding or high-risk procedures may optimize clot formation in advanced liver disease: hematocrit ≥25%, platelet count >50,000, and fibrinogen >120 mg/dL. Commonly utilized thresholds for international normalized ratio correction are not supported by evidence. BEST PRACTICE ADVICE 5: Thrombopoietin agonists are a good alternative to platelet transfusion, but require time (about 10 days) to elevate platelet levels. BEST PRACTICE ADVICE 6: The large volume of fresh frozen plasma required to reach an arbitrary international normalized ratio target, limitations of the usual target, minimal effect on thrombin generation, and adverse effects on portal pressure limit the utility of this agent significantly. BEST PRACTICE ADVICE 7: The 4-factor prothrombin complex concentrate contains both pro- and anticoagulant factors that offer an attractive low-volume therapeutic to rebalance a disturbed hemostatic system. However, dosage is, in part, based on international normalized ratio, which is problematic in cirrhosis, and published experience in liver disease is limited. BEST PRACTICE ADVICE 8: Anti-fibrinolytic therapy may be considered in patients with persistent bleeding from mucosal oozing or puncture wound bleeding consistent with impaired clot integrity. Both ε-aminocaproic acid and tranexamic acid inhibit clot dissolution. Neither is believed to generate a hypercoagulable state, although both may exacerbate pre-existing thrombi. BEST PRACTICE ADVICE 9: Desmopressin releases von Willebrand factor as its primary hemostatic mechanism. As this factor is usually elevated in cirrhosis, the agent lacks a sound evidence-based foundation, but may be useful in patients with concomitant renal failure. BEST PRACTICE ADVICE 10: Systemic heparin infusion is recommended for symptomatic deep vein thrombosis and portal and mesenteric vein thrombosis, but there are unresolved issues regarding monitoring with both the anti-Xa assay and the partial thromboplastin time due to cirrhosis-related antithrombin deficiency (heparin cofactor). BEST PRACTICE ADVICE 11: Treatment of incidental portal and mesenteric vein thrombosis depends on estimated impact on transplantation surgical complexity vs risks of bleeding and falls. Therapy with low-molecular-weight heparin, vitamin K antagonists, and direct-acting anticoagulants improve portal vein repermeation vs observation alone. BEST PRACTICE ADVICE 12: Direct-acting anticoagulants, such as the factor Xa and thrombin inhibitors, are relatively safe and effective in stable cirrhotic patients, but are in need of further study in patients with more advanced liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hanafy, A. S., Abd-Elsalam, S. M., & Dawoud, M. M. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.05.002 · Cited by 152
RetractedGarcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
Self-citationCohen, A. T., Tapson, V. F., Bergmann, J.-F., Goldhaber, S. Z., Kakkar, A. K., Deslandes, B., Huang, W., Zayaruzny, M., Emery, L., & Anderson, F. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60202-0 · Cited by 1,495
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Runyon, B. A. (2013) · Hepatology · doi:10.1002/hep.26359 · Cited by 778
Villa, E., Cammà, C., Marietta, M., Luongo, M., Critelli, R., Colopi, S., Tata, C., Zecchini, R., Gitto, S., Petta, S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.018 · Cited by 744
Lisman, T., Bongers, T. N., Adelmeijer, J., Janssen, H. L. A., de Maat, M. P. M., de Groot, P. G., & Leebeek, F. W. G. (2006) · Hepatology · doi:10.1002/hep.21231 · Cited by 605
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
Tripodi, A., Primignani, M., Chantarangkul, V., Dell'Era, A., Clerici, M., de Franchis, R., Colombo, M., & Mannucci, P. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.045 · Cited by 547
Haemostasis in chronic kidney disease
Lutz, J., Menke, J., Sollinger, D., Schinzel, H., & Thürmel, K. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft209 · Cited by 451
De Pietri, L., Bianchini, M., Montalti, R., De Maria, N., Di Maira, T., Begliomini, B., Gerunda, G. E., di Benedetto, F., Garcia‐Tsao, G., & Villa, E. (2016) · Hepatology · doi:10.1002/hep.28148 · Cited by 438
Wanless, I. R., Wong, F., Blendis, L. M., Greig, P., Heathcote, J. E., & Levy, G. (1995) · Hepatology · doi:10.1002/hep.1840210505 · Cited by 434
Søgaard, K. K., Horváth-Puhó, E., Grønbæk, H., Jepsen, P., Vilstrup, H., & Sørensen, H. T. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.34 · Cited by 424
Loffredo, L., Pastori, D., Farcomeni, A., & Violi, F. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.042 · Cited by 410
Northup, P. G., McMahon, M. M., Ruhl, A. P., Altschuler, S. E., Volk-Bednarz, A., Caldwell, S. H., & Berg, C. L. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00588.x · Cited by 381
Self-citationEltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Afdhal, N. H., Giannini, E. G., Tayyab, G., Mohsin, A., Lee, J.-W., Andriulli, A., Jeffers, L., McHutchison, J., Chen, P.-J., Han, K.-H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110709 · Cited by 321
Human plasma fibrinogen is synthesized in the liver
Tennent, G. A., Brennan, S. O., Stangou, A. J., O'Grady, J., Hawkins, P. N., & Pepys, M. B. (2007) · Blood · doi:10.1182/blood-2006-08-040956 · Cited by 304
Systematic review: portal vein thrombosis in cirrhosis
TSOCHATZIS, E. A., SENZOLO, M., GERMANI, G., GATT, A., & BURROUGHS, A. K. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04182.x · Cited by 285
Intagliata, N. M., Henry, Z. H., Maitland, H., Shah, N. L., Argo, C. K., Northup, P. G., & Caldwell, S. H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-4012-2 · Cited by 245
Self-citationBolliger, D., Szlam, F., Molinaro, R. J., Rahe-Meyer, N., Levy, J. H., & Tanaka, K. A. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep098 · Cited by 237
Portal vein thrombosis and survival in patients with cirrhosis
Englesbe, M. J., Kubus, J. J., Muhammad, W., Sonnenday, C. J., Welling, T. H., Punch, J. D., Lynch, R., Marrero, J. A., & Pelletier, S. J. (2009) · Liver Transplantation · doi:10.1002/lt.21941 · Cited by 235
Portal vein thrombosis and liver transplant survival benefit
Englesbe, M. J., Schaubel, D. E., Cai, S., Guidinger, M. K., & Merion, R. M. (2010) · Liver Transplantation · doi:10.1002/lt.22105 · Cited by 229
The risk of venous thromboembolism in patients with cirrhosis: A systematic review and meta-analysis
Ambrosino, P., Tarantino, L., Di Minno, G., Paternoster, M., Graziano, V., Petitto, M., Nasto, A., & Di Minno, M. N. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-06-0450 · Cited by 222
The Role of Donor-Specific HLA Alloantibodies in Liver Transplantation
O’Leary, J. G., Demetris, A. J., Friedman, L. S., Gebel, H. M., Halloran, P. F., Kirk, A. D., Knechtle, S. J., McDiarmid, S. V., Shaked, A., Terasaki, P. I., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12667 · Cited by 216
Self-citationCoagulation parameters and major bleeding in critically ill patients with cirrhosis
Drolz, A., Horvatits, T., Roedl, K., Rutter, K., Staufer, K., Kneidinger, N., Holzinger, U., Zauner, C., Schellongowski, P., Heinz, G., et al. (2016) · Hepatology · doi:10.1002/hep.28628 · Cited by 204
Intagliata, N. M., Argo, C. K., Stine, J. G., Lisman, T., Caldwell, S. H., Violi, F., & Disease, O. B. O. T. F. O. T. 7. I. C. I. L. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1666861 · Cited by 179
Self-citationEvidence that low protein C contributes to the procoagulant imbalance in cirrhosis
Tripodi, A., Primignani, M., Lemma, L., Chantarangkul, V., & Mannucci, P. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.036 · Cited by 178
WANLESS, I. (1995) · Hepatology · doi:10.1016/0270-9139(95)90043-8 · Cited by 175
Nagaoki, Y., Aikata, H., Daijo, K., Teraoka, Y., Shinohara, F., Nakamura, Y., Hatooka, M., Morio, K., Nakahara, T., Kawaoka, T., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12895 · Cited by 156
Wu, H. Y., & Nguyen, G. C. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.05.014 · Cited by 151
Stine, J. G., Shah, N. L., Argo, C. K., Pelletier, S. J., Caldwell, S. H., & Northup, P. G. (2015) · Liver Transplantation · doi:10.1002/lt.24134 · Cited by 148
Self-citationLow‐grade endotoxemia and platelet activation in cirrhosis
Raparelli, V., Basili, S., Carnevale, R., Napoleone, L., Del Ben, M., Nocella, C., Bartimoccia, S., Lucidi, C., Talerico, G., Riggio, O., et al. (2017) · Hepatology · doi:10.1002/hep.28853 · Cited by 142
Determinants of platelet count in humans
Daly, M. E. (2010) · Haematologica · doi:10.3324/haematol.2010.035287 · Cited by 137
Hugenholtz, G. C. G., Macrae, F. L., Adelmeijer, J., et al. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13278 · Cited by 134
Bellest, L., Eschwège, V., Poupon, R. Y., Chazouillères, O., & Robert, A. (2007) · Hepatology · doi:10.1002/hep.21680 · Cited by 131
Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis
Rautou, P., Bresson, J., Sainte–Marie, Y., Vion, A.-C., Paradis, V., Renard, J., Devue, C., Heymes, C., Lettéron, P., Elkrief, L., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.040 · Cited by 126
Nontumoral portal vein thrombosis in patients awaiting liver transplantation
Chen, H., Turón, F., Hernández–Gea, V., Fuster, J., García‐Criado, Á., Barrufet, M., Darnell, A., Fondevila, C., García‐Valdecasas, J. C., & García‐Pagán, J. C. (2015) · Liver Transplantation · doi:10.1002/lt.24387 · Cited by 121
Mandorfer, M., Schwabl, P., Paternostro, R., Pomej, K., Bauer, D. J. M., Thaler, J., Ay, C., Quehenberger, P., Fritzer‐Szekeres, M., Peck‐Radosavljevic, M., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14522 · Cited by 119
Tripodi, A., Chantarangkul, V., Primignani, M., Clerici, M., Dell’Era, A., Aghemo, A., & Mannucci, P. M. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0528-4 · Cited by 112
Hibbert, R. M., Atwell, T. D., Lekah, A., Patel, M. D., Carter, R. E., McDonald, J. S., & Rabatin, J. T. (2013) · CHEST Journal · doi:10.1378/chest.12-2374 · Cited by 101
Hyperfibrinolytic Activity in Hospitalized Cirrhotic Patients in a Referral Liver Unit
Hu, K., Yu, A. S., Tiyyagura, L., Redeker, A. G., & Reynolds, T. B. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03781.x · Cited by 93
Kalambokis, G. N., Oikonomou, A., Christou, L., Kolaitis, N. I., Tsianos, E. V., Christodoulou, D. K., & Baltayiannis, G. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.002 · Cited by 91
Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis
Anstee, Q. M., Wright, M., Goldin, R. D., & Thursz, M. R. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.09.013 · Cited by 85
Hung, A., & García–Tsao, G. (2018) · Liver International · doi:10.1111/liv.13712 · Cited by 73
Goriacko, P., & Veltri, K. T. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13045 · Cited by 72
Anticoagulation in chronic liver disease
Dhar, A., Mullish, B. H., & Thursz, M. R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.006 · Cited by 50
Correction of hemostatic abnormalities and portal pressure variations in patients with cirrhosis
Giannini, E. G., Stravitz, R. T., & Caldwell, S. H. (2014) · Hepatology · doi:10.1002/hep.27029 · Cited by 45
Self-citationReversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward
Intagliata, N. M., Maitland, H. S., Pellitier, S. M., & Caldwell, S. H. (2016) · Liver Transplantation · doi:10.1002/lt.24708 · Cited by 38
Self-citationÖzdemir, Z. C., Kar, Y. D., Gündüz, E., Turhan, A. B., & Bör, Ö. (2018) · Hematology · doi:10.1080/10245332.2018.1452456 · Cited by 28
Howard, B. M., Kornblith, L. Z., Redick, B. J., Conroy, A. S., Nelson, M. F., Calfee, C. S., Callcut, R. A., & Cohen, M. J. M. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001716 · Cited by 21
Cited by
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Kaplan, D. E., Ripoll, C., Thiele, M., Fortune, B. E., Simonetto, D. A., Garcia-Tsao, G., & Bosch, J. (2024) · Hepatology · doi:10.1097/hep.0000000000000647 · Cited by 486
Neuberger, J., Patel, J., Caldwell, H., Davies, S., Hebditch, V., Hollywood, C., Hubscher, S., Karkhanis, S., Lester, W., Roslund, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321299 · Cited by 449
Kietaibl, S., Ahmed, A., Afshari, A., Albaladejo, P., Aldecoa, C., Barauskas, G., De Robertis, E., Faraoni, D., Filipescu, D. C., Fries, D., et al. (2023) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001803 · Cited by 345
Metadata
- Authors
- O’Leary, J. G., Greenberg, C. S., Patton, H. M., & Caldwell, S. H.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 157
- Issue
- 1
- Pages
- 34-43.e1
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2809833128
- Cited by
- 450
- References
- 50
- FWCI
- 29.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.